- About this Journal
- Abstracting and Indexing
- Aims and Scope
- Annual Issues
- Article Processing Charges
- Articles in Press
- Author Guidelines
- Bibliographic Information
- Citations to this Journal
- Contact Information
- Editorial Board
- Editorial Workflow
- Free eTOC Alerts
- Publication Ethics
- Reviewers Acknowledgment
- Submit a Manuscript
- Subscription Information
- Table of Contents
Journal of Biomedicine and Biotechnology
Volume 2010 (2010), Article ID 620827, 7 pages
Oral Microencapsulated Live Saccharomyces cerevisiae Cells for Use in Renal Failure Uremia: Preparation and In Vivo Analysis
Biomedical Technology and Cell Therapy Research Laboratory, Department of Biomedical Engineering, Faculty of Medicine, McGill University, Duff Medical Building, 3775 University Street, Montréal, QC, Canada H3A 2B4
Received 9 February 2010; Accepted 21 April 2010
Academic Editor: Ali Khraibi
Copyright © 2010 Razek Coussa et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- H. R. Brady, M. R. Clarkson, and W. Lieberthal, “Acute renal failure,” in Brenner & Rector's the Kidney, B. M. Brenner, Ed., pp. 1215–1292, W. B. Saunders, Philadelphia, Pa, USA, 2004.
- J. Coresh, B. C. Astor, T. Greene, G. Eknoyan, and A. S. Levey, “Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey,” American Journal of Kidney Diseases, vol. 41, no. 1, pp. 1–12, 2003.
- R. Thadhani, M. Pascual, and J. V. Bonventre, “Acute renal failure,” The New England Journal of Medicine, vol. 334, no. 22, pp. 1448–1460, 1996.
- W. Lieberthal and S. K. Nigam, “Acute renal failure. II. Experimental models of acute renal failure: imperfect but indispensable,” American Journal of Physiology, vol. 278, no. 1, pp. F1–F12, 2000.
- S. K. Nigam and W. Lieberthal, “Acute renal failure. III. The role of growth factors in the process of renal regeneration and repair,” American Journal of Physiology, vol. 279, no. 1, pp. F3–F11, 2000.
- R. W. Schrier and W. Wang, “Acute renal failure and sepsis,” The New England Journal of Medicine, vol. 351, no. 22, pp. 2347–2349, 2004.
- S. Charles, M. David, and M. Stacia, “Control of body fluid, electrolyte, and acid−base balance,” in Human Physiology: Foundations and Frontiers, A. Deborah, Ed., pp. 526–527, Times-Mirror College Publications, Sant Louis, Mo, USA, 1990.
- H. Asaba, et al., “Plasma middle molecules in asymptomatic and sick uremic patients,” in Middle Molecules in Uremia and Other Diseases, H. Klinkmann, et al., Ed., pp. 137–141, International Society for Artificial Organs, Cleveland, Ohio, USA, 1980.
- B. D. Cohen, “Uremic toxins,” in Uremia: An International Conference on Pathogenesis, Diagnosis and Therapy, R. Kulte, B. Geoffrey, and B. C. Benjamin, Eds., pp. 1–11, Thieme, Stuttgart, Germany, 1972.
- W. J. Kolff, “Artificial kidney and artificial heart: further considerations,” International Journal of Artificial Organs, vol. 13, no. 7, pp. 404–406, 1990.
- R. Esposito, G. Carmelo, and G. Polyhalides, Sorbents and Their Clinical Applications, Academic Press, London, UK, 1980.
- W. Drukker, P. M. Parsons, and J. F. Mahar, Replacement of Renal Functions by Dialysis, Martinus Nijhoff, Boston, Mass, USA, 1983.
- E. A. Friedman, “Future treatment of renal failure,” in Strategy in Renal Failure, E. A. Friedman, Ed., pp. 521–528, John Wiley & Sons, New York, NY, USA, 1978.
- S. Prakash and T. M. S. Chang, “Microencapsulated genetically engineered E. coli DH5 cells for plasma urea and ammonia removal based on : 1. Column bioreactor and 2. Oral administration in uremic rats,” Artificial Cells, Blood Substitutes, and Immobilization Biotechnology, vol. 24, no. 3, pp. 201–218, 1996.
- B. Hoppe, G. von Unruh, N. Laube, A. Hesse, and H. Sidhu, “Oxalate degrading bacteria: new treatment option for patients with primary and secondary hyperoxaluria?” Urological Research, vol. 33, no. 5, pp. 372–375, 2005.
- M. L. Jones, H. Chen, W. Ouyang, T. Metz, and S. Prakash, “Microencapsulated genetically engineered Lactobacillus plantarum 80 (pCBH1) for bile acid deconjugation and its implication in lowering cholesterol,” Journal of Biomedicine and Biotechnology, vol. 2004, no. 1, pp. 61–69, 2004.
- C. Kjellstrand, H. Borges, C. Pru, D. Gardner, and D. Fink, “On the clinical use of microencapsulated zirconium phosphate-urease for the treatment of chronic uremia,” Transactions of the American Society for Artificial Internal Organs, vol. 27, pp. 24–30, 1981.
- R. E. Sparks, N. S. Mason, P. M. Meier, W. E. Samuels, M. H. Litt, and O. Lindan, “Binders to remove uremic waste metabolites from the GI tract,” Transactions of the American Society for Artificial Internal Organs, vol. 18, pp. 458–464, 1972.
- R. E. Sparks, “Review of gastrointestinal perfusion in the treatment of uremia,” Clinical Nephrology, vol. 11, no. 2, pp. 81–85, 1979.
- J. M. Walker, R. L. Jacobson, W. J. Stephen, and D. Rose, “The role of adsorbents in the wearable artificial kidney,” in Artificial Organs, T. Gilchrist, Ed., pp. 137–149, Macmillan Press, London, UK, 1977.
- T. Agishi, N. Yamashita, and K. Ota, “Clinical results of direct charcoal hemoperfusion for endogenous and exogenous intoxication,” in Hemoperfusion, Part I, S. Sidemen and T. M. S. Chang, Eds., pp. 255–263, Hemisphere, Washington, DC, USA, 1980.
- K. F. Gu and T. M. S. Chang, “Conversion of alpha-ketoglutarate into L-glutamic acid with urea as ammonia source using multienzyme system and NAD immobilized by microencapsulation with artificial cell in bioreactor,” Biotechnology and Bioengineering, vol. 32, pp. 363–368, 1988.
- K. F. Gu and T. M. S. Chang, “Conversion of urea or ammonia into essential amino acids, L-leucine, L-valine and L-isoleucine using artificial cells containing an immobilized multienzyme system and dextran-NAD: yeast alcohol dehydrogenase for enzyme recycling,” Journal of Applied Biochemistry and Biotechnology, vol. 12, pp. 227–236, 1991.
- M. V. Cattaneo and T. M. S. Chang, “The potential of a microencapsulated urease-zeolite oral sorbent for the removal of urea in uremia,” Transactions of American Society for Artificial Internal Organs, vol. 37, no. 2, pp. 80–87, 1991.
- T. M. S. Chang, “Semipermeable microcapsules,” Science, vol. 146, no. 3643, pp. 524–525, 1964.
- T. M. S. Chang, Semipermeable aqueous microcapsules, Ph.D. thesis, McGill University, Montreal, Canada, 1965.
- T. M. Chang, F. C. MacIntosh, and S. G. Mason, “Semipermeable aqueous microcapsules. I. Preparation and properties,” Canadian Journal of Physiology and Pharmacology, vol. 44, no. 1, pp. 115–128, 1966.
- L. S. Meriwether and H. M. Kramer, “In vitro reactivity of oxystarch and oxycellulose,” Kidney International, Supplement, no. 7, pp. S259–265, 1976.
- S. Prakash and T. M. S. Chang, “Artificial cells and genetically engineered microencapsulated for E. coli cells, for urea and ammonia removal,” Methods in Molecular Biology, vol. 23, pp. 343–357, 1996.
- K. Iseki, S. Oshiro, M. Tozawa, C. Iseki, Y. Ikemiya, and S. Takishita, “Significance of hyperuricemia on the early detection of renal failure in a cohort of screened subjects,” Hypertension Research, vol. 24, no. 6, pp. 691–697, 2001.
- X. Wu, M. Wakamiya, S. Vaishnav et al., “Hyperuricemia and urate nephropathy in urate oxidase-deficient mice,” Proceedings of the National Academy of Sciences of the United States of America, vol. 91, no. 2, pp. 742–746, 1994.
- K. Hirayama and J. Rafter, “The role of lactic acid bacteria in colon cancer prevention: mechanistic considerations,” Antonie van Leeuwenhoek, vol. 76, no. 1–4, pp. 391–394, 1999.
- F. Guarner, “Enteric flora in health and disease,” Digestion, vol. 73, pp. 5–12, 2006.